SKNY closed today higher at CA$0.2, an increase of 0% from yesterday's close, completing a monthly decrease of -48.7179% or -CA$0.19. Over the past 12 months, SKNY stock lost -89.6373%.
SKNY is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NEO-L (CAD).
Has LIR Life Sciences Corp. ever had a stock split?
No, there has never been a stock split.
LIR Life Sciences Corp. Profile
Metals & MiningIndustry
MaterialsSector
Dr. Edward Mills Ph.D.CEO
CNSXExchange
-ISIN
USCountry
-Employees
-Last Dividend
-Last Split
-IPO Date
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
Contact Information
Address:1505 W 2nd Ave, Vancouver, BC, Canada, V6J 1H2